MBX Biosciences (MBX) Insider Trading & Ownership $12.25 -0.11 (-0.89%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$12.24 -0.01 (-0.04%) As of 05/21/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock MBX Biosciences (NYSE:MBX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage52.19%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$20.60 MNumber OfInsiders Selling(Last 12 Months)0 Get MBX Insider Trade Alerts Want to know when executives and insiders are buying or selling MBX Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MBX Insider Buying and Selling by Quarter MBX Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/8/2025Ora H PescovitzDirectorBuy7,693$5.89$45,311.77 2/18/2025Carl L GordonDirectorBuy143,170$10.84$1,551,962.80 2/14/2025Carl L GordonDirectorBuy47,502$9.87$468,844.74 2/4/2025P. Kent HawrylukCEOBuy50,000$10.69$534,500.00 9/16/2024Edward T MathersDirectorBuy500,000$16.00$8,000,000.00 9/16/2024Life Sciences X L.P. FrazierMajor ShareholderBuy625,000$16.00$10,000,000.00 (Data available from 1/1/2013 forward) MBX Insider Trading Activity - Frequently Asked Questions Who is on MBX Biosciences's Insider Roster? The list of insiders at MBX Biosciences includes Carl L Gordon, Edward T Mathers, Life Sciences X L.P. Frazier, Ora H Pescovitz, and P. Kent Hawryluk. Learn more on insiders at MBX. What percentage of MBX Biosciences stock is owned by insiders? 52.19% of MBX Biosciences stock is owned by insiders. Learn more on MBX's insider holdings. Which MBX Biosciences insiders have been buying company stock? The following insiders have purchased MBX shares in the last 24 months: Carl L Gordon ($2,020,807.54), Edward T Mathers ($8,000,000.00), Life Sciences X L.P. Frazier ($10,000,000.00), Ora H Pescovitz ($45,311.77), and P. Kent Hawryluk ($534,500.00). How much insider buying is happening at MBX Biosciences? Insiders have purchased a total of 1,373,365 MBX shares in the last 24 months for a total of $20,600,619.31 bought. MBX Biosciences Key ExecutivesMr. Peter Kent Hawryluk (Age 55)CEO, President & Director Compensation: $571.2k1 recent tradesDr. Steven J. Prestrelski M.B.A. (Age 60)MBA, Ph.D., Chief Scientific Officer Mr. Matt GambinoVice President of MarketingMs. Michelle Graham (Age 57)Chief Human Resources Officer Dr. Salomon Azoulay (Age 67)Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Biohaven Insider Trading IDEAYA Biosciences Insider Trading Edgewise Therapeutics Insider Trading Immunocore Insider Trading Travere Therapeutics Insider Trading Structure Therapeutics Insider Trading Janux Therapeutics Insider Trading ARS Pharmaceuticals Insider Trading Adaptive Biotechnologies Insider Trading Vera Therapeutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NYSE:MBX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
